Your browser doesn't support javascript.
loading
Pemetrexed versus gefitinib as a second-line treatment in advanced nonsquamous nonsmall-cell lung cancer patients harboring wild-type EGFR (CTONG0806): a multicenter randomized trial.
Zhou, Q; Cheng, Y; Yang, J-J; Zhao, M-F; Zhang, L; Zhang, X-C; Chen, Z-H; Yan, H-H; Song, Y; Chen, J-H; Feng, W-N; Xu, C-R; Wang, Z; Chen, H-J; Zhong, W-Z; Liu, Y-P; Wu, Y-L.
Afiliación
  • Zhou Q; Department of Pulmonary Oncology, Guangdong Lung Cancer Institute, Guangdong General Hospital and Guangdong Academy of Medical Sciences, Guangzhou.
  • Cheng Y; Department of Pulmonary Oncology, Jilin Provincial Cancer Hospital, Changchun.
  • Yang JJ; Department of Pulmonary Oncology, Guangdong Lung Cancer Institute, Guangdong General Hospital and Guangdong Academy of Medical Sciences, Guangzhou.
  • Zhao MF; Department of Medical Oncology, The First Hospital of China Medical University, Shenyang.
  • Zhang L; Department of Respiratory Medicine, Perking Union Medical Hospital, Beijing.
  • Zhang XC; Department of Pulmonary Oncology, Guangdong Lung Cancer Institute, Guangdong General Hospital and Guangdong Academy of Medical Sciences, Guangzhou.
  • Chen ZH; Department of Pulmonary Oncology, Guangdong Lung Cancer Institute, Guangdong General Hospital and Guangdong Academy of Medical Sciences, Guangzhou.
  • Yan HH; Department of Pulmonary Oncology, Guangdong Lung Cancer Institute, Guangdong General Hospital and Guangdong Academy of Medical Sciences, Guangzhou.
  • Song Y; Department of Respiratory Medicine, Jinling Hospital, Nanjing University School of Medicine, Nanjing.
  • Chen JH; Department of Medical Oncology, Hunan Cancer Hospital, Changsha.
  • Feng WN; Department of Medical Oncology, The First People's Hospital of Foshan, Foshan, China.
  • Xu CR; Department of Pulmonary Oncology, Guangdong Lung Cancer Institute, Guangdong General Hospital and Guangdong Academy of Medical Sciences, Guangzhou.
  • Wang Z; Department of Pulmonary Oncology, Guangdong Lung Cancer Institute, Guangdong General Hospital and Guangdong Academy of Medical Sciences, Guangzhou.
  • Chen HJ; Department of Pulmonary Oncology, Guangdong Lung Cancer Institute, Guangdong General Hospital and Guangdong Academy of Medical Sciences, Guangzhou.
  • Zhong WZ; Department of Pulmonary Oncology, Guangdong Lung Cancer Institute, Guangdong General Hospital and Guangdong Academy of Medical Sciences, Guangzhou.
  • Liu YP; Department of Medical Oncology, The First Hospital of China Medical University, Shenyang.
  • Wu YL; Department of Pulmonary Oncology, Guangdong Lung Cancer Institute, Guangdong General Hospital and Guangdong Academy of Medical Sciences, Guangzhou. Electronic address: syylwu@live.cn.
Ann Oncol ; 25(12): 2385-2391, 2014 Dec.
Article en En | MEDLINE | ID: mdl-25281710
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Quinazolinas / Carcinoma de Pulmón de Células no Pequeñas / Receptores ErbB / Glutamatos / Guanina / Neoplasias Pulmonares Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2014 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Quinazolinas / Carcinoma de Pulmón de Células no Pequeñas / Receptores ErbB / Glutamatos / Guanina / Neoplasias Pulmonares Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2014 Tipo del documento: Article